Veracyte (NASDAQ: VCYT) reported Q3 EPS of $0.51, $0.19 better than the analyst estimate of $0.32. Revenue for the quarter came in at $131.9 million versus the consensus estimate of $124.78 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $506-510 million, versus the consensus of $500.2 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.